Roche says wins priority review for Avastin in cervical cancer

July 15, 2014 9:49 AM

7 0

Roche says wins priority review for Avastin in cervical cancer

ZURICH (Reuters) - Swiss drugmaker Roche said U.S. health regulators have granted a priority review of its Avastin drug when combined with chemotherapy to treat women with cervical cancer.

An approval by the U.S. Food and Drug Administration for treating advanced cervical cancer would open another large market for the medicine in patients for whom chemotherapy has been largely ineffective. About 4,000 women in the United States and 250,000 worldwide die each year from the disease.

Also read: Donald Trump Speaks To Taiwan's President, Reversing Decades Of U.S. Policy

Read more

To category page

Loading...